Search
Now showing items 1-1 of 1
Development and characterization of novel a TCRm antibody and its application as an immune checkpoint blocker
(2021-12-21)
Immunotherapy, the treatment of diseases via targeted immune system activation, has recently shown extraordinary success in clinical trials for multiple malignancies. In contrast to a routine therapeutic regimen for cancer, ...